What’s On The Trauma Professional’s Blog?

In the previous post, I reviewed some basic information on DOAC reversal. Five years ago, it was costly and questionably effective. So what has happened in the meantime? In this post, I’ll review a big trial the pharma company was excited about and make a few comments. ANNEXA-I Study This... Read more